{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T10:11:56Z","timestamp":1766830316238},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s13721-022-00378-y","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T20:02:17Z","timestamp":1663790537000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["5-HTR2B and SLC6A3 as potential molecular targets of sertraline in the treatment of major depressive disorder: the use of bioinformatics and its practical implication"],"prefix":"10.1007","volume":"11","author":[{"given":"Ronaldo R.","family":"de Oliveira","sequence":"first","affiliation":[]},{"given":"Diana","family":"Kuhn","sequence":"additional","affiliation":[]},{"given":"Daiane","family":"Heidrich","sequence":"additional","affiliation":[]},{"given":"Fl\u00e1vio M.","family":"Shansis","sequence":"additional","affiliation":[]},{"given":"Rodrigo G.","family":"Ducati","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds Fernando S. M.","family":"Timmers","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"378_CR1","first-page":"12.16.1","volume":"79","author":"S Aggarwal","year":"2018","unstructured":"Aggarwal S, Mortensen OV (2018) Overview of monoamine transporters. Curr Protoc Pharmacol 79:12.16.1-12.16.17","journal-title":"Curr Protoc Pharmacol"},{"key":"378_CR2","unstructured":"APA, 2013. Diagnostic and statistical manual of mental disorders DSM 5, 5a. ed, 5a. Ed. Rev. Porto Alegre Artmed."},{"key":"378_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbr.2018.10.028","volume":"359","author":"A Bahi","year":"2019","unstructured":"Bahi A, Dreyer JL (2019) Dopamine transporter (DAT) knockdown in the nucleus accumbens improves anxiety- and depression-related behaviors in adult mice. Behav Brain Res 359:104\u2013115","journal-title":"Behav Brain Res"},{"key":"378_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/npp.2010.173","volume":"36","author":"SM Banas","year":"2011","unstructured":"Banas SM, Doly S, Boutourlinsky K, Diaz SL, Belmer A, Callebert J, Collet C, Launay JM, Maroteaux L (2011) Deconstructing antiobesity compound action: requirement of serotonin 5-HT 2B receptors for dexfenfluramine anorectic effects. Neuropsychopharmacology 36:423\u2013433","journal-title":"Neuropsychopharmacology"},{"key":"378_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2019.00091","volume":"13","author":"A Baudry","year":"2019","unstructured":"Baudry A, Pietri M, Launay JM, Kellermann O, Schneider B (2019) Multifaceted regulations of the serotonin transporter: impact on antidepressant response. Front Neurosci 13:1\u201313","journal-title":"Front Neurosci"},{"key":"378_CR6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41386-018-0013-0","volume":"43","author":"A Belmer","year":"2018","unstructured":"Belmer A, Quentin E, Diaz SL, Guiard BP, Fernandez SP, Doly S, Banas SM, Pitychoutis PM, Moutkine I, Muzerelle A, Tchenio A, Roumier A, Mameli M, Maroteaux L (2018) Positive regulation of raphe serotonin neurons by serotonin 2B receptors. Neuropsychopharmacology 43:1623\u20131632","journal-title":"Neuropsychopharmacology"},{"key":"378_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","volume":"20","author":"P Belujon","year":"2017","unstructured":"Belujon P, Grace AA (2017) Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol 20:1036\u20131046","journal-title":"Int J Neuropsychopharmacol"},{"key":"378_CR8","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M (2007) Canonical sampling through velocity rescaling. J Chem Phys 126:014101","journal-title":"J Chem Phys"},{"key":"378_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jocn.2017.05.022","volume":"43","author":"D Chen","year":"2017","unstructured":"Chen D, Meng L, Pei F, Zheng Y, Leng J (2017) A review of DNA methylation in depression. J Clin Neurosci 43:39\u201346","journal-title":"J Clin Neurosci"},{"key":"378_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41594-019-0253-7","volume":"26","author":"MH Cheng","year":"2019","unstructured":"Cheng MH, Bahar I (2019) Monoamine transporters: structure, intrinsic dynamics and allosteric regulation. Nat Struct Mol Biol 26:545\u2013556","journal-title":"Nat Struct Mol Biol"},{"key":"378_CR12","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Ruhe HG, Furukawa TA, Tajika A, Egger M, Hayasaka Y, Higgins JPT, Atkinson LZ, Shinohara K, Ioannidis JPA, Leucht S, Ogawa Y, Salanti G, Takeshima N, Imai H, Turner EH, Chaimani A, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391:1357\u20131366","journal-title":"Lancet"},{"key":"378_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jad.2016.03.023","volume":"197","author":"S D\u2019Souza","year":"2016","unstructured":"D\u2019Souza S, Thompson JMD, Slykerman R, Marlow G, Wall C, Murphy R, Ferguson LR, Mitchell EA, Waldie KE (2016) Environmental and genetic determinants of childhood depression: the roles of DAT1 and the antenatal environment. J Affect Disord 197:151\u2013158","journal-title":"J Affect Disord"},{"key":"378_CR14","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) Swisstargetprediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357\u2013W364","journal-title":"Nucleic Acids Res"},{"key":"378_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.neuropharm.2011.01.025","volume":"61","author":"SL Diaz","year":"2011","unstructured":"Diaz SL, Maroteaux L (2011) Implication of 5-HT2B receptors in the serotonin syndrome. Neuropharmacology 61:495\u2013502","journal-title":"Neuropharmacology"},{"key":"378_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/mp.2011.159","volume":"17","author":"SL Diaz","year":"2012","unstructured":"Diaz SL, Doly S, Narboux-Nme N, Fern\u00e1ndez S, Mazot P, Banas SM, Boutourlinsky K, Moutkine I, Belmer A, Roumier A, Maroteaux L (2012) 5-HT 2B receptors are required for serotonin-selective antidepressant actions. Mol Psychiatry 17:154\u2013163","journal-title":"Mol Psychiatry"},{"key":"378_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.euroneuro.2015.12.012","volume":"26","author":"SL Diaz","year":"2016","unstructured":"Diaz SL, Narboux-N\u00eame N, Boutourlinsky K, Doly S, Maroteaux L (2016) Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants. Eur Neuropsychopharmacol 26:265\u2013279","journal-title":"Eur Neuropsychopharmacol"},{"key":"378_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/gte.2007.0089","volume":"12","author":"O Dogan","year":"2008","unstructured":"Dogan O, Yuksel N, Ergun MA, Yilmaz A, Ilhan MN, Karslioglu HE, Koc A, Menevse A (2008) Serotonin transporter gene polymorphisms and sertraline response in major depression patients. Genet Test 12:225\u2013231","journal-title":"Genet Test"},{"key":"378_CR19","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1523\/JNEUROSCI.5723-07.2008","volume":"28","author":"S Doly","year":"2008","unstructured":"Doly S, Valjent E, Setola V, Callebert J, Herv\u00e9 D, Launay JM, Maroteaux L (2008) Serotonin 5-HT2B receptors are required for 3,4- methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. J Neurosci 28:2933\u20132940","journal-title":"J Neurosci"},{"key":"378_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0007952","volume":"4","author":"S Doly","year":"2009","unstructured":"Doly S, Bertran-Gonzalez J, Callebert J, Bruneau A, Banas SM, Belmer A, Boutourlinsky K, Herv\u00e9 D, Launay JM, Maroteaux L (2009) Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice. PLoS ONE 4:1\u201310","journal-title":"PLoS ONE"},{"key":"378_CR21","doi-asserted-by":"publisher","first-page":"10372","DOI":"10.1523\/JNEUROSCI.1354-17.2017","volume":"37","author":"S Doly","year":"2017","unstructured":"Doly S, Quentin E, Eddine R, Tolu S, Fernandez SP, Bertran-Gonzalez J, Valjent E, Belmer A, Vi\u00f1als X, Callebert J, Faure P, Meye FJ, Herv\u00e9 D, Robledo P, Mameli M, Launay JM, Maldonado R, Maroteaux L (2017) Serotonin 2B receptors in mesoaccumbens dopamine pathway regulate cocaine responses. J Neurosci 37:10372\u201310388","journal-title":"J Neurosci"},{"key":"378_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/ejn.14630","volume":"53","author":"RS Duman","year":"2021","unstructured":"Duman RS, Deyama S, Foga\u00e7a MV (2021) Role of BDNF in the pathophysiology and treatment of depression: activity-dependent effects distinguish rapid-acting antidepressants. Eur J Neurosci 53:126\u2013139","journal-title":"Eur J Neurosci"},{"key":"378_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00213-003-1562-3","volume":"174","author":"LK Durham","year":"2004","unstructured":"Durham LK, Webb SM, Milos PM, Clary CM, Seymour AB (2004) The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology 174:525\u2013529","journal-title":"Psychopharmacology"},{"key":"378_CR24","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1021\/ci200377u","volume":"51","author":"H Fan","year":"2011","unstructured":"Fan H, Schneidman-Duhovny D, Irwin JJ, Dong G, Shoichet BK, Sali A (2011) Statistical potential for modeling and ranking of protein-ligand interactions. J Chem Inf Model 51:3078\u20133092","journal-title":"J Chem Inf Model"},{"key":"378_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pharmthera.2010.04.003","volume":"127","author":"JA Fishback","year":"2010","unstructured":"Fishback JA, Robson MJ, Xu YT, Matsumoto RR (2010) Sigma receptors: potential targets for a new class of antidepressant drug. Pharmacol Ther 127:271\u2013282","journal-title":"Pharmacol Ther"},{"key":"378_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2016-014912","volume":"7","author":"G Gartlehner","year":"2017","unstructured":"Gartlehner G, Wagner G, Matyas N, Titscher V, Greimel J, Lux L, Gaynes BN, Viswanathan M, Patel S, Lohr KN (2017) Pharmacological and non- pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open 7:1\u201313","journal-title":"BMJ Open"},{"key":"378_CR27","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09629","volume":"468","author":"D Goldman","year":"2010","unstructured":"Goldman D, Bevilacqua L, Doly S, Kaprio J, Yuan Q, Tikkanen R, Paunio T, Zhou Z, Wedenoja J, Maroteaux L, Diaz S, Belmer A, Colin AH, Dell\u2019Osso L, Suvisaari J, Coccaro E, Rose RJ, Peltonen L, Virkkunen M (2010) A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature 468:1061\u20131068","journal-title":"Nature"},{"key":"378_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","volume":"17","author":"AA Grace","year":"2016","unstructured":"Grace AA (2016) Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci 17:524\u2013532","journal-title":"Nat Rev Neurosci"},{"key":"378_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","volume":"75","author":"DS Hasin","year":"2018","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF (2018) Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiat 75:336\u2013346","journal-title":"JAMA Psychiat"},{"key":"378_CR30","first-page":"1","volume":"9","author":"L Hertz","year":"2015","unstructured":"Hertz L, Rothman DL, Li B, Peng L (2015) Chronic ssri stimulation of astrocytic 5- HT2B receptors change multiple gene expressions\/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift. Front Behav Neurosci 9:1\u201317","journal-title":"Front Behav Neurosci"},{"key":"378_CR31","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463\u20131472","journal-title":"J Comput Chem"},{"key":"378_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","volume":"85","author":"C Hiemke","year":"2000","unstructured":"Hiemke C, H\u00e4rtter S (2000) Pharmacokinetics of the selective serotonin reuptake inhibitors. Pharmacol Ther 85:11\u201320","journal-title":"Pharmacol Ther"},{"key":"378_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/mp.2015.53","volume":"21","author":"F Hieronymus","year":"2016","unstructured":"Hieronymus F, Emilsson JF, Nilsson S, Eriksson E (2016) Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry 21:523\u2013530","journal-title":"Mol Psychiatry"},{"key":"378_CR34","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.3390\/ijms11083016","volume":"11","author":"SY Huang","year":"2010","unstructured":"Huang SY, Zou X (2010) Advances and challenges in protein-ligand docking. Int J Mol Sci 11:3016\u20133034","journal-title":"Int J Mol Sci"},{"key":"378_CR35","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926","journal-title":"J Chem Phys"},{"key":"378_CR36","doi-asserted-by":"publisher","first-page":"107322","DOI":"10.1016\/j.compbiolchem.2020.107322","volume":"87","author":"LP Kagami","year":"2020","unstructured":"Kagami LP, das Neves GM, Timmers LFSM, Caceres RA, Eifler-Lima VL (2020) Geo-measures: A PyMOL plugin for protein structure ensembles analysis. Comput Biol Chem. 87:107322","journal-title":"Comput Biol Chem."},{"key":"378_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"SH Kennedy","year":"2016","unstructured":"Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, M\u00fcller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R (2016) Canadian Network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3 pharmacological treatments. Can J Psychiatry 61:540\u2013560","journal-title":"Can J Psychiatry"},{"key":"378_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/sj.tpj.6500398","volume":"7","author":"J Kirchheiner","year":"2007","unstructured":"Kirchheiner J, Nickchen K, Sasse J, Bauer M, Roots I, Brockm\u00f6ller J (2007) A 40- basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. Pharmacogenomics J 7:48\u201355","journal-title":"Pharmacogenomics J"},{"key":"378_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejphar.2010.08.026","volume":"647","author":"Y Kitaichi","year":"2010","unstructured":"Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kakuta A, Izumi T, Koyama T (2010) Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol 647:90\u201396","journal-title":"Eur J Pharmacol"},{"key":"378_CR40","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1523\/JNEUROSCI.0576-11.2011","volume":"31","author":"MB Larsen","year":"2011","unstructured":"Larsen MB, Sonders MS, Mortensen OV, Larson GA, Zahniser NR, Amara SG (2011) Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation. J Neurosci 31:6605\u20136615","journal-title":"J Neurosci"},{"key":"378_CR41","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1096\/fj.06-5724com","volume":"20","author":"J Launay","year":"2006","unstructured":"Launay J, Schneider B, Loric S, Prada MD, Kellermann O (2006) Serotonin transport and serotonin transporter- mediated antidepressant recognition are controlled by 5- HT2B receptor signaling in serotonergic neuronal cells. FASEB J 20:1843\u20131854","journal-title":"FASEB J"},{"key":"378_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/17460441.2016.1190706","volume":"11","author":"A Lee","year":"2016","unstructured":"Lee A, Lee K, Kim D (2016) Using reverse docking for target identification and its applications for drug discovery. Expert Opin Drug Discov 11:707\u2013715","journal-title":"Expert Opin Drug Discov"},{"key":"378_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-019-0412-y","volume":"9","author":"M Li","year":"2019","unstructured":"Li M, D\u2019Arcy C, Li X, Zhang T, Joober R, Meng X (2019) What do DNA methylation studies tell us about depression? A systematic review. Transl Psychiatry 9:1\u201314","journal-title":"Transl Psychiatry"},{"key":"378_CR44","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ (2018) Depression. Lancet 392:2299\u20132312","journal-title":"Lancet"},{"key":"378_CR45","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41594-018-0116-7","volume":"25","author":"JD McCorvy","year":"2018","unstructured":"McCorvy JD, Wacker D, Wang S, Agegnehu B, Liu J, Lansu K, Tribo AR, Olsen RHJ, Che T, Jin J, Roth BL (2018) Structural determinants of 5-HT2B receptor activation and biased agonism. Nat Struct Mol Biol 25:787\u2013796","journal-title":"Nat Struct Mol Biol"},{"key":"378_CR46","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/1471-2105-14-286","volume":"14","author":"IH Moal","year":"2013","unstructured":"Moal IH, Torchala M, Bates PA, Fern\u00e1ndez-Recio J (2013) The scoring of poses in protein-protein docking: current capabilities and future directions. BMC Bioinformatics 14:286","journal-title":"BMC Bioinformatics"},{"key":"378_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1176\/appi.ajp.2016.15101334","volume":"174","author":"S Moriguchi","year":"2017","unstructured":"Moriguchi S, Yamada M, Takano H, Nagashima T, Takahata K, Yokokawa K, Ito T, Ishii T, Kimura Y, Zhang MR, Mimura M, Suhara T (2017) Norepinephrine transporter in major depressive disorder: a PET study. Am J Psychiatry 174:36\u201341","journal-title":"Am J Psychiatry"},{"key":"378_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2018.11.004","volume":"122","author":"KG Mulvihill","year":"2019","unstructured":"Mulvihill KG (2019) Presynaptic regulation of dopamine release: role of the DAT and VMAT2 transporters. Neurochem Int 122:94\u2013105","journal-title":"Neurochem Int"},{"key":"378_CR49","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jad.2011.08.033","volume":"136","author":"D Mushtaq","year":"2012","unstructured":"Mushtaq D, Ali A, Margoob MA, Murtaza I, Andrade C (2012) Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder. J Affect Disord 136:955\u2013962","journal-title":"J Affect Disord"},{"key":"378_CR50","doi-asserted-by":"crossref","unstructured":"Naga Madhavilatha, K., Rama Mohan Babu, G., 2019. Systematic approach for enrichment of docking outcome using consensus scoring functions. J. Phys. Conf. Ser. 1228.","DOI":"10.1088\/1742-6596\/1228\/1\/012019"},{"key":"378_CR51","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/nn.3778","volume":"17","author":"YS Nikolova","year":"2014","unstructured":"Nikolova YS, Koenen KC, Galea S, Wang CM, Seney ML, Sibille E, Williamson DE, Hariri AR (2014) Beyond genotype: serotonin transporter epigenetic modification predicts human brain function. Nat Neurosci 17:1153\u20131155","journal-title":"Nat Neurosci"},{"key":"378_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1017\/S1092852918001207","volume":"24","author":"Z Pan","year":"2019","unstructured":"Pan Z, Park C, Brietzke E, Zuckerman H, Rong C, Mansur RB, Fus D, Subramaniapillai M, Lee Y, McIntyre RS (2019) Cognitive impairment in major depressive disorder. CNS Spectr 24:22\u201329","journal-title":"CNS Spectr"},{"key":"378_CR53","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/0706743716659418","volume":"61","author":"SV Parikh","year":"2016","unstructured":"Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Ravindran AV, Uher R (2016) Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2 psychological treatments. Can J Psychiatry 61:524\u2013539","journal-title":"Can J Psychiatry"},{"issue":"4","key":"378_CR54","first-page":"271","volume":"128","author":"G Parker","year":"2013","unstructured":"Parker G, Blanch B, Paterson A, Hadzi-Pavlovic D, Sheppard E, Manicavasagar V, Synnott H, Graham RK, Friend P, Gilfillan D, Perich T (2013) The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: a 12-week single-blind randomized study. Acta Psychiatr Scand 128(4):271\u2013281","journal-title":"Acta Psychiatr Scand"},{"key":"378_CR55","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.euroneuro.2017.08.427","volume":"27","author":"M Peci\u00f1a","year":"2017","unstructured":"Peci\u00f1a M, Sikora M, Avery ET, Heffernan J, Peci\u00f1a S, Mickey BJ, Zubieta J-K (2017) Striatal dopamine D2\/3 receptor-mediated neurotransmission in major depression: implications for anhedonia, anxiety and treatment response. Eur Neuropsychopharmacol 27:977\u2013986","journal-title":"Eur Neuropsychopharmacol"},{"key":"378_CR56","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/cap.2019.0017","volume":"29","author":"EA Poweleit","year":"2019","unstructured":"Poweleit EA, Aldrich SL, Martin LJ, Hahn D, Strawn JR, Ramsey LB (2019) Pharmacogenetics of sertraline tolerability and response in pediatric anxiety and depressive disorders. J Child Adolesc Psychopharmacol 29:348\u2013361","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"378_CR57","doi-asserted-by":"publisher","first-page":"OT19037BR3","DOI":"10.4088\/JCP.OT19037BR3","volume":"81","author":"R Rafeyan","year":"2020","unstructured":"Rafeyan R, Papakostas GI, Jackson WC, Trivedi MH (2020) Inadequate response to treatment in major depressive disorder: augmentation and adjunctive strategies. J Clin Psychiatry 81:OT19037BR3","journal-title":"J Clin Psychiatry"},{"key":"378_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-019-0997-0","volume":"21","author":"J Rehm","year":"2019","unstructured":"Rehm J, Shield KD (2019) Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep 21:1\u20137","journal-title":"Curr Psychiatry Rep"},{"key":"378_CR59","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1389450119666181022153016","volume":"20","author":"S Saikia","year":"2019","unstructured":"Saikia S, Bordoloi M (2019) Molecular docking: challenges, advances and its use in drug discovery perspective. Curr Drug Targets 20:501\u2013521","journal-title":"Curr Drug Targets"},{"key":"378_CR60","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ajmg.b.32578","volume":"177","author":"A Salatino-Oliveira","year":"2018","unstructured":"Salatino-Oliveira A, Rohde LA, Hutz MH (2018) The dopamine transporter role in psychiatric phenotypes. Am J Med Genet B Neuropsychiatr Genet 177:211\u2013231","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"378_CR61","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A \u0160ali","year":"1993","unstructured":"\u0160ali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779\u2013815","journal-title":"J Mol Biol"},{"key":"378_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/YIC.0000000000000023","volume":"29","author":"C Sanchez","year":"2014","unstructured":"Sanchez C, Reines EH, Montgomery SA (2014) A comparative review of escitalopram, paroxetine, and sertraline: are they all alike? Int Clin Psychopharmacol 29:185\u2013196","journal-title":"Int Clin Psychopharmacol"},{"key":"378_CR63","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/FPC.0b013e32833132cb","volume":"19","author":"K Sangkuhl","year":"2009","unstructured":"Sangkuhl K, Klein TE, Altman RB (2009) Selective serotonin reuptake inhibitors pathway. Pharmacogenet Genomics 19:907\u2013909","journal-title":"Pharmacogenet Genomics"},{"key":"378_CR64","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1110\/ps.062416606","volume":"15","author":"M Shen","year":"2006","unstructured":"Shen M, Sali A (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci 15:2507\u20132524","journal-title":"Protein Sci"},{"key":"378_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0011067","volume":"5","author":"E Shumay","year":"2010","unstructured":"Shumay E, Fowler JS, Volkow ND (2010) Genomic features of the human dopamine transporter gene and its potential epigenetic states: Implications for phenotypic diversity. PLoS ONE 5:1\u201317","journal-title":"PLoS ONE"},{"key":"378_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"AW Sousa da Silva","year":"2012","unstructured":"Sousa da Silva AW, Vranken WF (2012) ACPYPE - antechamber python parser interface. BMC Res Notes 5:367","journal-title":"BMC Res Notes"},{"key":"378_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/gtmb.2013.0217","volume":"18","author":"J Staeker","year":"2014","unstructured":"Staeker J, Leucht S, Laika B, Steimer W (2014) Polymorphisms in serotonergic pathways influence the outcome of antidepressant therapy in psychiatric inpatients. Genet Test Mol Biomarkers 18:20\u201331","journal-title":"Genet Test Mol Biomarkers"},{"key":"378_CR68","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/bioinformatics\/btl150","volume":"22","author":"K Stierand","year":"2006","unstructured":"Stierand K, Maa\u00df PC, Rarey M (2006) Molecular complexes at a glance: Automated generation of two-dimensional complex diagrams. Bioinformatics 22:1710\u20131716","journal-title":"Bioinformatics"},{"key":"378_CR69","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","volume":"36","author":"G Studer","year":"2020","unstructured":"Studer G, Rempfer C, Waterhouse AM, Gumienny R, Haas J, Schwede T (2020) QMEANDisCo\u2014distance constraints applied on model quality estimation. Bioinformatics 36:1765\u20131771","journal-title":"Bioinformatics"},{"key":"378_CR70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2967\/jnumed.108.053652","volume":"50","author":"EM van de Giessen","year":"2009","unstructured":"van de Giessen EM, De Win MML, Tanck MWT, Van Den Brink W, Baas F, Booij J (2009) Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50:45\u201352","journal-title":"J Nucl Med"},{"key":"378_CR71","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D van Der Spoel","year":"2005","unstructured":"van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701\u20131718","journal-title":"J Comput Chem"},{"key":"378_CR72","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/acps.12987","volume":"139","author":"WA van Eeden","year":"2019","unstructured":"van Eeden WA, van Hemert AM, Carlier IVE, Penninx BW, Giltay EJ (2019) Severity, course trajectory, and within-person variability of individual symptoms in patients with major depressive disorder. Acta Psychiatr Scand 139:194\u2013205","journal-title":"Acta Psychiatr Scand"},{"key":"378_CR73","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2124","volume":"7","author":"A Vangone","year":"2017","unstructured":"Vangone A, Bonvin AMJJ (2017) PRODIGY: a contact-based predictor of binding affinity in protein-protein complexes. Bio-Protoc 7:e2124","journal-title":"Bio-Protoc"},{"key":"378_CR74","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature14431","volume":"521","author":"KH Wang","year":"2015","unstructured":"Wang KH, Penmatsa A, Gouaux E (2015) Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521:322\u2013327","journal-title":"Nature"},{"key":"378_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-016-0130-x","volume":"8","author":"Z Wang","year":"2016","unstructured":"Wang Z, Liang L, Yin Z, Lin J (2016) Improving chemical similarity ensemble approach in target prediction. J Cheminform 8:1\u201310","journal-title":"J Cheminform"},{"key":"378_CR76","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1038\/tp.2016.137","volume":"6","author":"E Won","year":"2016","unstructured":"Won E, Choi S, Kang J, Kim A, Han KM, Chang HS, Tae WS, Son KR, Joe SH, Lee MS, Ham BJ (2016) Association between reduced white matter integrity in the corpus callosum and serotonin transporter gene DNA methylation in medication-naive patients with major depressive disorder. Transl Psychiatry 6:e866\u2013e869","journal-title":"Transl Psychiatry"},{"key":"378_CR77","unstructured":"World Health Organization, 2020. Depression [WWW Document]. January 30, 2020. URL https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression (accessed 7.5.20)."},{"key":"378_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s41048-017-0045-8","volume":"4","author":"X Xu","year":"2018","unstructured":"Xu X, Huang M, Zou X (2018) Docking-based inverse virtual screening: methods, applications, and challenges. Biophys Rep 4:1\u201316","journal-title":"Biophys Rep"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-022-00378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-022-00378-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-022-00378-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:34:34Z","timestamp":1670056474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-022-00378-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1007\/s13721-022-00378-y","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"value":"2192-6662","type":"print"},{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"34"}}